law firms Amit, Pollak, Matalon & Co. Advocates & Notary Main address Nitsba Tower, 17 Yitzhak Sadeh St., 19th floor, Tel Aviv 67775 Israel Yonatan Altman, Chairman Telephone / Fax 972-3-568-9000 / 972-3-568-9001 yonatan@apm-law.com Legal staff number 72 www.apm-law.com APM & Co. is a renowned Israeli law firm with a robust legal practice. Established in 1956, the firm draws on over 57 years of excellence to offer an up-to-date and innovative approach to the practice of law. The firm provides a comprehensive range of legal services to an Israeli and international client base that spans across all business sectors. APM & Co. s main areas of expertise are corporate law, mergers and acquisitions, capital markets and securities, high-tech, fund formation, intellectual property, international and local taxation, finance, antitrust, bankruptcy, liquidation and reorganization, real estate, labor law, projects and energy, regulatory and compliance, environmental law and litigation. APM & Co. is consistently ranked in leading international and local directories of the legal profession, such as Chambers & Partners, EMEA Legal 500, Dun s 100 and BdiCoface. APM & Co. s high-tech and venture capital practice is one of the most sophisticated and established practices in Israel. The firm s client base includes entrepreneurs, startups, technology companies, angel investors, institutional investors, technological incubators and private equity and venture capital funds both domestic and foreign. The firm has extensive experience in all types of high-tech and venture capital transactions, including investments (all stages), securities offerings, mergers and acquisitions, joint ventures and multilateral international agreements. APM & Co. gives particular attention to the needs of entrepreneurs and startups seeking counsel on formation, founders agreements, fundraising and structuring of the business model. Time and again, APM & Co. has supported its clients ongoing activities, investment rounds and business expansion up through multi-million dollar exit transactions. APM & Co. s deep knowledge of the market enables the firm to be instrumental in representing newly established funds and fund managers in changing fundraising environments. The firm has formed a significant number of funds and is seen as a market leader in the fund formation domain. Drawing upon vast experience accumulated through its longstanding operation in the high-tech ecosystem, APM & Co. couples legal services of the highest standard with sound business judgment to offer top representation that makes a difference. Selected matters handled by our high-tech practice: Representation of NCR Corporation in the acquisition of Retalix Ltd. for approximately $650 million. Representation of MediGuide in its acquisition by St. Jude Medical for $300 million. Representation of Traffix Communication Systems Ltd. since its participation in the incubator program of The Time Innovations Ltd. (another client of the firm). Traffix was sold to the US software developer F5 Networks for $135 million. Establishment of Vintage Investment Fund, Genesis Partners and Fortissimo Capital Fund (private equity fund); conducting negotiations with their respective investors and representing the funds in their investments. Service Providers IVC 2013 Yearbook 167
accounting firms BDO Ziv Haft Address Amot Bituach House, Bldg. B, 46-48 Menachem Begin Road, Tel Aviv 66180 Israel Michal Yashar, Marketing Communications Manager Telephone / Fax 972-3-638-0152 / 972-3-638-0157 michaly@bdo.co.il www.bdo.co.il Partners/managers Shlomo Ziv, President & Founder; Dan Margalit, Chairman & CEO; Erez Soffer, Managing Partner; Shahar Ziv, Managing Partner High-Tech Division Yaniv Cohen, Partner & Head of High-Tech Division; Lavy Giat, Senior Partner; Lior Shahar, Partner; Avi Oz, Partner; David Wertheimer, Partner; Asaf Ravkaie, Partner Consulting Group Pini Shmueli Nisan, Partner; Yigal Toledano, Partner; Yaron Peled, Partner; Sharon Witkowski Tabib, Partner; Keren Kibovich, Partner; Tal Dolev, Partner; Shaul Ben-Shimol, Partner Tax Eyal Rubin, Senior Tax Partner; Eli Alice, International Tax Partner Description BDO Ziv Haft is a dynamic, business-oriented accounting and consulting firm, ranking among the five leading firms in Israel. Established in 1983, BDO Ziv Haft is part of the BDO International network, one of the world s five leading accounting and business consulting networks. The BDO network is represented in more than 138 countries and deployed in over 1,204 offices with 54,933 employees throughout the world. BDO Ziv Haft s membership in the BDO network enables the firm s clients to receive personalized and reliable local services in a wide range of areas in business centers worldwide. BDO Ziv Haft maintains six branches across Israel with more than 1,200 employees, as well as Israel desks in India and China and an accounting office in Georgia. The firm is proud of its highly professional and experienced high-tech group, which accompanies companies from seed to exit and beyond. We offer specialized expertise in sectors as diverse as software, IT, hardware, Internet, telecom, wireless, semiconductors, medical devices, pharmaceuticals, cleantech and more. We integrate business advisory, accounting and tax services into a single unit. The services we provide include: Auditing and accounting. Auditing (PCAOB, ICFR, US/ISRAELI GAAS, ISA, SAS 70, etc.) & Accounting (SEC Reporting, US GAAP, IFRS, ISEC Reporting & ISRAELI GAAP) Raising private and public capital. Our strong global network comprised of investment banks, venture capital firms and private investors uniquely positions us to create connections between investors and high-tech companies. We have extensive experience in taking high-tech firms public in Israel, the US, the UK and Asia. Local and international tax consultancy. We provide diversified tax services, including consulting, obtaining pre-rulings, international taxation (in conjunction with the international BDO network) and employee stock option plans. M&A activity. Includes structuring and restructuring deals Valuations and due diligence. Planning and implementation of financial information technologies. Systems analysis & design, EDP auditing, ERP, CRM, balanced scorecard, performance management, security services and business intelligence Government funds. Verification of eligibility and preparation and submission of reports to assist clients seeking government funding for business ventures 160 IVC 2013 Yearbook Service Providers
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC Offices Boston, Massachusetts; London, UK; Los Angeles, California; New York, New York; San Diego, California; San Francisco, California; Stamford, Connecticut; Washington, DC Israel liaison office Sderot Abba Eban 8, Building B, 1st Floor, PO Box 12018, Herzliya Pituach 46120 Yael Biran, Managing Director - Mintz Levin Israel Business Telephone / Fax 972-(0)9-773-6346 / 972-(0)9-958-1759 ybiran@mintz.com Expertise www.mintz.com M&A, financings, securities, government contracts, import and export control, employment and immigration, intellectual property, licensing, litigation, real estate, environmental law, tax, antitrust, bankruptcy Partners/managers Robert I. Bodian, Managing Member Staff number 1,000 Description No matter where your business is in its growth cycle, you will benefit by having legal advisers who know your industry and have the experience to help you reach your goals. Mintz Levin offers a full range of international legal services and a dedicated Israel Business Group to help you achieve your global business objectives. Whether your work involves information technology, life sciences, energy and clean technology, or another innovation, our attorneys can help you tap into new markets, access new financing opportunities or bring a new idea to the marketplace. We regularly advise companies in all phases of their growth from startup to multinational expansion and help take private companies public and vice versa. With an office in London, seven US locations and a liaison office in Herzliya Pituach, we are well positioned to facilitate Israel-related business internationally. We have extensive business relationships with Israel-based companies and US and European companies doing business in Israel. Our Israel Business Group serves a variety of clients in a broad spectrum of matters, including general corporate work, intellectual property, litigation, employment, immigration and regulatory matters. We are committed to the Israeli marketplace and are proud of our success in facilitating Israel-related business internationally. Our attorneys will leverage their deep industry knowledge, international connections, and profound understanding of business and financial markets for your benefit. We look forward to helping you drive results. Areas of focus Employment law General corporate counseling Immigration Intellectual property Litigation Regulatory counseling Startups Venture capital Industry focus Energy and clean technology Healthcare Information technology Life sciences Telecommunications and media 182 IVC 2013 Yearbook Service Providers
Canaan Partners Address (Israel) Ackerstein Towers, Bldg B., 11 Hamenofim St., 10th floor, Herzliya Pituach 46120 Israel Telephone / Fax 972-9-972-6858 / 972-9-972-6859 Izhar Shay, Gil Canaani ishay@canaan.com; gcanaani@canaan.com www.canaan.com Partners/managers Izhar Shay, General Partner Capital managed/advised $3.5 billion Capital available for investment $600 million Fund investment focus Technology and healthcare Year established 1987 Minimum investment $1 million Maximum investment $20 million Investment stages Seed to late stage Office locations California, Connecticut, NY, India, Israel Top-Tier Track Record Canaan Partners is a global venture capital firm that invests in entrepreneurs who turn visionary ideas into valuable and significant companies. We were early investors in some of the world s leading technology companies, including Acme Packet, SandForce, CommerceOne, DoubleClick, Match.com, Kabam and Active Network, as well as very successful healthcare companies such as Cerexa, Dexcom, Northstar Neuroscience, Peninsula Pharmaceuticals, Chimerix, Liquidia and Advanced BioHealing. Out of more than 300 investments, Canaan has realized more than 135 successful exits, positioning it as one of the world s top-tier venture capital funds. With $3.5 billion under management, Canaan is currently investing out of its 9th fund of $600 million, which closed in 2012. Providing Added Value to Entrepreneurs Canaan Partners does not just invest money in a company. We invest our time, experience, intimate knowledge, wide connections and team approach in every venture we take on. Our goal is to create lasting partnerships with entrepreneurs and management teams who have the same drive to succeed as we do. We offer our portfolio companies ample support, including assistance in the development and review of company strategies; help in the recruitment of key senior management; assistance in the structuring and negotiating of strategic alliances; access to Canaan s network of portfolio companies, limited partners and contacts within the business and financial communities; and global support through Canaan s offices on both US coasts and across the globe. Canaan remains committed long after the initial investment, working hard to help companies grow over time. Our investment capabilities range from $1 million to $20 million, and we have the ability and the team to invest in any stage of development from seed financings to late stage investments. Committed to the Israeli Market In 2006, as part of its global expansion strategy, Canaan opened offices in Gurgaon, India and Herzliya, Israel. The expansion of its Israeli office signals Canaan s long term commitment to investing in Israeli innovation. Canaan s Israeli team leverages the background and experience of its local members, combined with the expertise of its international teams, to support Israeli portfolio companies with a wide range of capabilities and reach. In the technology sector, we focus on investments in digital media, internet, enterprise software, semiconductors, communications and mobility. In the healthcare sector, we seek investments in medical devices, diagnostics and biopharmaceuticals. Israeli portfolio companies Company name Mobilitec Business Layers Efficient Finance LiveU Peer39 EnStorage Prime Sense N-Trig CallMyName Viewbix Sector Cellular (sold to Alcatel-Lucent) Enterprise Software (sold to Netegrity) Financial Services Communications / Video Internet (sold to DG Inc.) Energy / Cleantech Semiconductor / Consumer Electronics Semiconductor / Consumer Electronics Mobile Communications New Media / Video Foreign Investors IVC 2013 Yearbook 145
Hamilton Lane Main address Nolton House, 14 Shenkar Street, PO Box 12279, Herzliya Pituach 46733 Israel Limor Beker, Managing Director Juan Delgado-Moreira, Managing Director Telephone 972-9-958-6670 Fax 972-9-956-8205 lbeker@hamiltonlane.com jdelgado-moreira@hamiltonlane.com www.hamiltonlane.com Partners/managers 65 (Vice President and above) Year established 1991 Type of firm Private equity management (Private equity offerings include customized separate accounts, funds-of-funds, advisory services and fund administration services) Capital managed/advised As of December 31, 2012: $23.8 billion in managed account assets (discretionary) $147.4 billion in assets under supervision (non-discretionary) $171.2 billion in total assets under management and supervision Investment stages Diversified Industry preferences Diversified Geographical preferences Global Hamilton Lane is an independent financial institution that provides discretionary and non-discretionary private equity asset management services to sophisticated investors worldwide. Headquartered outside of Philadelphia, Pennsylvania and with offices in several US cities, London, Hong Kong, Rio de Janeiro, Tokyo, Tel Aviv and Singapore, Hamilton Lane offers a full range of investment products and services that enable clients to participate in the private equity asset class on a global and customized basis. Founded in 1991, Hamilton Lane currently has more than 190 employees and approximately $23.8 billion of discretionary assets under management.* We have a global, sophisticated client base that includes public and corporate pension funds, sovereign wealth funds, Taft-Hartley funds, financial institutions, insurance companies, foundations, endowments and high net worth individuals. Our clients include a number of the world s largest institutional investors, as well as many mid-sized and smaller institutions. *As of December 31, 2012 Foreign Investors IVC 2013 Yearbook 149
Merck Serono Address 18 Ha kishon St., Yavne 81220 Israel Telephone +972-8-938-2424 Fax +972-8-940-7566 Dr. Simone Botti Head of Israel Bioincubator Fund simone.botti@merckgroup.com www.merckserono.co.il Merck Serono s R&D Center in Israel Inter-Lab (ITL) Inter-Lab, an integral part of Merck Serono s global biotechnology research and development organization, carries out research and development projects in collaboration with other groups within the company. Inter-Lab functions as a center of expertise for the development of high producer cells, which serve in the development and production of new drugs. Since the development of Rebif and other drugs, Inter-Lab scientists have gained decades of experience in process development and manufacturing technologies specific to biotechnology. Today, these stateof-the-art technologies are used in genetic engineering and the development of high-producing cells. In parallel, Inter-Lab is continuously developing new technologies and platforms for production of therapeutics. High producer cell development is a multi-disciplinary field. Inter-Lab scientists include those from all disciplines of biology and biochemistry, working together in the company s state-of-the-art Yavne-based facilities. Merck Serono Israel Bioincubator Fund Merck Serono s Israel bioincubator fund is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry. Merck Serono is launching the bioincubator program in Israel, one of the world s top-ranking countries for biomedical research, where it has a longstanding presence. The bioincubator offers both seed financing and access to dedicated, state-of-the-art laboratory facilities within Inter-Lab, Merck Serono s Israel-based research and development center. Merck Serono is committing a total of EUR 10 million to the bioincubator initiative through 2018. Israeli startups are currently being selected based on their potential for developing innovative technologies aligned with Merck Serono s strategic focus. By nurturing biotech startups at an early stage of development, the company is seeking to secure innovations for future application in its focus business areas of oncology, neurodegenerative diseases, rheumatology, fertility and endocrinology. 152 IVC 2013 Yearbook Foreign Investors